Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Eden Prairie, USA
7700 Equitable Drive
Suite 206
Eden Prairie, MN, 55344
USA

People

CFO
Vice President of Research and Development
Board of Directors
Chairman and CEO

Funding

TOTAL $8.43M
FUNDING TOTAL $8.43M
Series A, 6/2009
$3.36M
Series B, 7/2011
$5.07M
DEBT TOTAL $3M
Debt, 10/2013
Square 1 Bank
$3M

Tags

NeoChord

NeoChord, Inc., is a venture backed medical device company that has developed a proprietary device that allows mitral valve repair to be performed on a beating heart through a 2 to 3 inch incision between the ribs in patients with severe, degenerative mitral valve regurgitation. In contrast, most mitral valve repair procedures are performed through a 3 to 10 inch chest incision (sternotomy) which involves cutting through the sternum, opening the rib cage, stopping the heart and placing the patient on bypass.

Recent Milestones

Videos

Screenshots

NeoChord screenshot
Above: Homepage
Uploaded: 10/8/13

Sources

  1. SEC (sec.gov) [edit]
  2. SEC (sec.gov) [edit]
  3. NeoChord Closes $3M Credit Facility with Square 1 Bank (finsmes.com) [edit]
Edit This Page
Last Edited 3/4/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy